Athersys Reports First Quarter 2016 Results
CLEVELAND, May 05, 2016 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the three months ended March 31, 2016.
Highlights of the first quarter of 2016 and recent events include:
- Announced positive one-year follow-up results from the Phase 2 study of MultiStem® cell therapy to treat ischemic stroke – demonstrating progressive improvements and significantly higher rate of excellent outcomes at one year for MultiStem-treated patients – with greater benefits for patients receiving MultiStem treatment within 36 hours of the stroke;
Highlights of the first quarter of 2016 and recent events include:
- Announced positive one-year follow-up results from the Phase 2 study of MultiStem® cell therapy to treat ischemic stroke – demonstrating progressive improvements and significantly higher rate of excellent outcomes at one year for MultiStem-treated patients – with greater benefits for patients receiving MultiStem treatment within 36 hours of the stroke;